The notion that miR-21 mediates gefitinib resistance was confirmed further by the study demonstrating that intra-tumour administration with anti-miR-21 oligonucleotides antagonized the elevation of Akt in both total and phosphorylated forms in gefitinib-resistant PC9 tumours [34]. Here, AKT1 is linked to neoplasm.